Platelets are vital for hemostasis because they release their granule contents in response to vascular damage. Platelet exocytosis is mediated by soluble NSF attachment protein receptors (SNAREs) whose interactions are governed by regulators e.g. Sec/Munc18 (SM) proteins. These proteins chaperone syntaxin t-SNAREs and are required for exocytosis.
ABSTRACT:
Platelets are vital for hemostasis because they release their granule contents in response to vascular damage. Platelet exocytosis is mediated by soluble NSF attachment protein receptors (SNAREs) whose interactions are governed by regulators e.g. Sec/Munc18 (SM)
proteins. These proteins chaperone syntaxin t-SNAREs and are required for exocytosis.
Platelets contain three Munc18 isoforms: Munc18a, Munc18b, and Munc18c. We report that Munc18b is the major isoform and is required for platelet secretion. Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL5) is caused by defects in the Munc18b/STXBP2 gene. We confirmed a previous report (Sandrock et al. 2010) showing that platelets from FHL5 patients have defective secretion. Serotonin, ADP/ATP, and platelet factor 4 (PF4) release was profoundly affected in the two biallelic patients and partially in a heterozygous patient. Release of lysosomal contents was only affected in the biallelic platelets. Platelets from the FHL5 biallelic patients showed decreased Munc18b and syntaxin-11 levels were significantly reduced; other syntaxins were unaffected. Munc18b formed complexes with syntaxin-11, SNAP-23, and VAMP-8 in human platelets. Other potential secretion regulators, Munc13-4 and Rab27, were also found associated. These data demonstrate a key role for Munc18b, perhaps as a limiting factor, in platelet exocytosis and suggest that it regulates syntaxin-11.
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INTRODUCTION:
Circulating platelets play a key role in hemostasis and its sequelae. Upon vascular injury, platelets adhere to the damaged site, become activated, and secrete their granule contents. There are three granule classes in platelets: α-granules, dense granules, and lysosomes. Proteomic studies show that platelets contain and secrete hundreds of bioactive molecules that are important for vascular integrity. For example, α-granules contain molecules (e.g. fibrinogen, PF4, Factor V), which are important for platelet adhesion and aggregation, clot formation, wound healing, angiogenesis, and inflammation.
1,2 Dense granules contain small molecules that are important for promoting platelet activation (e.g.
serotonin, ADP, and Ca 2+
). 3 Lysosomes contain hydrolytic enzymes (e.g. β-hexosaminidase), which may contribute to thrombus remodeling. 4 Given its importance, it is critical to understand platelet exocytosis at a mechanistic level since elements of the secretory process may prove to be viable therapeutic targets for controlling thrombosis.
The platelet release reaction is mediated by soluble N-ethylmaleimide-Sensitive
Factor Attachment Protein Receptors (SNAREs) and SNARE regulators. 5 There are two general classes of SNARE proteins: target membrane SNAREs (t-SNAREs) and granule/vesicle-associated SNAREs (v-SNAREs). t-SNAREs and v-SNAREs form a complex that spans the two fusing bilayers (target and granule membrane); it is that complex that is minimally required for membrane fusion and subsequent granule cargo release. is broadly expressed and has been shown to interact with syntaxin-1A, -1B, -2, and -3.
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Munc18b plays a role in exocytosis from mast cells, 17 neutrophils 18 and natural killer (NK) cells. 19, 20 Munc18c (also called STXBP3, PSP, or Munc18-3) is ubiquitously expressed, 21, 22 and can interact with both syntaxin-2, and -4. The interaction between Munc18c and syntaxin-4 is important for insulin release from adipose tissue and muscle cells and is important in endothelial cell activation. [23] [24] [25] In human and mouse platelets, three Munc18 isoforms are present: Munc18a, Munc18b, 26, 27 Using inhibitory peptides, (based on a potential regulatory site in Munc18s:
Pep3) or anti-Munc18 antibodies, our group showed that at least one Munc18 isoform is important for platelet secretion. 27 In permeabilized platelets, the Pep3 peptide inhibited release from all three granules classes. Using a monoclonal anti-Munc18c antibody and a cocktail of inhibitory peptides that disrupted Munc18c-syntaxin-4 interactions, Houng et al.
showed the potential importance of Munc18c-syntaxin-4 interactions. 26 Additionally, both
Munc18a and 18c are phosphorylated upon platelet stimulation, resulting in reduced affinity for their cognate syntaxins. 26, 27 The relevance of this was not established. Despite the apparent importance of Munc18c, platelets from Munc18c heterozygous mice, which had a ~30% reduction in the protein, showed no secretion defect. 28 These divergent results suggested that more information is required before assigning function to the platelet Munc18 syntaxin-2, -4, and -7, -Munc18c, and -Rab27a were described in. [7] [8] [9] 33 The rabbit anti-Munc18b and anti-syntaxin-11 polyclonal antibodies were produced in our laboratory.
FITC-labeled anti-human P-selectin was from BD Pharmingen TM (San Jose, CA Figure 1A and B). Platelet Secretion Analysis: Control and patient blood were collected using ACD as anti-coagulant. Platelet secretion was measured as described. 8, 9 Washed platelets were labeled with 0.4 μCi/mL Platelets were diluted 10-fold with HEPES-Tyrode buffer (pH 6.5). Fluorescent intensities of the platelets were measured using FACScan TM flow cytometer and analyzed using CellQuest TM (BD Biosciences).
Genotype of FHL5
Platelet Aggregation and ATP Release: Human platelets were prepared as discussed above, recalcified with 0.7 mM CaCl 2 , placed into siliconized cuvettes, and stirred for 5 min at 37°C
at 800 rpm. Luciferin-luciferase substrate was added to the platelet samples followed by the indicated agonists. ATP secretion was monitored using a Model 460VS Lumi-Dual aggregometer and traces were acquired using a Model 810 Aggro/Link interface with Aggro/Link software (Chrono-Log).
Ultrastructure Analysis: Washed, human platelets were either kept resting or stimulated with 0.1 U/mL of thrombin for 3 min. The platelets were then processed for electron microscopy as described previously with slight modification. 7, 10 Briefly, equal volumes of 0.1% glutaraldehyde in White's saline 38 were added to the platelet suspension for 15 min at 37°C.
The platelets were centrifuged and incubated in ice-cold 3% glutaraldehyde in White's saline at 4°C for 1 hr. After three washes, the platelets were incubated with 1% OsO 4 . Osmicated samples were washed twice and dehydrated with a series of ethanol solutions. The platelets were rinsed twice with propylene oxide and infiltrated overnight in a 1:1 mixture of propylene oxide and Spurr's resin (10 g vinyl cyclohexane dioxide (VCD), 6 g DER epoxy resin, 26 g nonenyl succinic anhydride (NSA) with final addition of 0.4 g dimethylaminoethanol (DMAE)). After several washes in pure Spurr's resin, samples were embedded in 150 µL Spurr's resin and polymerized in a 60°C incubator for 48 hr.
Polymerized blocks were sectioned (70 nM) and mounted on copper grids. Following counterstaining with uranyl acetate and lead citrate, samples were examined using Philips
Tecnai 12 transmission electron microscope (FEI, Hillsboro, OR) and images were obtained with Gatan Digitalmicrograph software (Pleasanton, CA).
Immunoprecipitation of Platelet SNAREs and Regulatory Proteins:
Washed platelets were prepared for immunoprecipitations as previously described. 39 For Munc18b
immunoprecipitations, resting and stimulated platelets were incubated with 2x Lysis buffer (2% n-octyl β-D-glucopyranoside; 2 mM EGTA; 2 mM EDTA; 100 mM HEPES; 150 mM NaCl; 
RESULTS:
Munc18b is the More Abundant Munc18 Isoform in Normal Human Platelets: Platelets express Munc18a, Munc18b, and Munc18c. 27 To determine the relative abundance of these three isoforms, recombinant proteins were first used to assess antibody specificity and then to generate standard curves for quantitative western blotting using enhanced chemi-fluorescence (ECF). ECF coupled with the Typhoon Imager system offers a more linear response curve with a greater range than do other methods e.g. enhanced chemi-luminescence ( Figure 1A ).
The specificity of the anti-Munc18a, -Munc18b, and -Munc18c antibodies used for this analysis was assessed by comparing their immuno-reactivities to known amounts of the recombinant Munc18 proteins ( Figure 1B) . The anti-Munc18a rabbit monoclonal antibody shows a small degree of cross-reactivity to Munc18c. The goat anti-Munc18b antibody (used for quantification) was isoform-specific while the rabbit anti-Munc18b did cross-react, slightly, with Munc18a. The anti-Munc18c antibody showed some cross-reactivity to Munc18a and even less to Munc18b. These limited cross-reactivities do affect the absolute accuracy of our analysis because they were not subtracted from our measurements; however, this has only a modest effect on their utility in ranking the per platelet levels of the three Munc18 isoforms. Acknowledging these limitations, it was estimated that there were ~2. 
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Munc18b is the more abundant Munc18 isoform in human platelets. 26, 28, 40 however, these conclusions were not supported by studies with heterozygous, Munc18c knockout mice, whose platelets did not have a secretion defect. 28 FHL5 is linked to a defect in the Munc18b/STXBP2 gene which provides a unique opportunity to examine Munc18b's role in platelet function. In Figure 1C and 1D, Munc18b was undetectable in platelets from the two biallelic patients (P1 and P2). The heterozygous patient (P3) showed a ~30% reduction. Munc18a increased in both biallelic samples, but this increase was apparently not sufficient to compensate for the loss of Munc18b (see Figure 2 and 3).
Characterization of Munc18s and SNARE Proteins in FHL5 Platelets
Munc18c levels were unchanged ( Figure 1C, D) . These data indicate that the mutations in the two biallelic patients (P1 and P2) cause the production of an unstable Munc18b protein, which was not detectible in platelets. The mutation in the heterozygous patient (P3) had less effect on Munc18b protein levels.
Loss of a Munc18 isoform often correlates with the loss of a specific syntaxin isoform and vice-versa, consistent with the syntaxin chaperone function of Munc18s. 41 In Figure 1C and 1D, the loss of Munc18b caused a striking decrease in syntaxin-11 with limited effects on syntaxin-4 (syntaxin-2, -7, and SNAP-23 were unchanged in biallelic patient (P1), data not shown). This is consistent with other studies of T-cells from FHL5 patients. 19, 20 VAMP-8, Munc13-4 (FHL3), and Rab27a levels were unaffected. While not proof of a direct interaction, these data are consistent with Munc18b acting as a chaperone for syntaxin-11 in platelets.
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Thrombin-Stimulated Secretion is Defective in FHL5 Platelets:
To address the functional ramifications of the loss of Munc18b, dose-response, secretion assays were performed to examine platelet exocytosis from biallelic and heterozygous FHL5 patients (Figure 2A and 2B, respectively). In Figure 2A , increasing concentrations of thrombin were used to stimulate platelets and the release from dense granules, α-granules, and lysosomes was measured. In control platelets (dark circles), there was a dose-dependent increase in serotonin, PF4 and β-hexosaminidase secretion that reached a maximum between 0.3 and 0.5 U/mL thrombin.
Platelets from the biallelic patient (P1, open circles) exhibited a severe defect in release from both dense and α-granules, even at the highest concentration of thrombin used (0.5 U/mL).
β-hexosaminidase release was also affected compared to the control; however, this defect seemed to be overcome when higher concentrations of thrombin were used. Similar effects were seen in the second biallelic patient (P2, data not shown).
The heterozygous FHL5 patient (P3) showed a partial secretion defect ( Figure 2B ).
Serotonin and PF4 release from P3's platelets were attenuated and did not reach the same extent as seen for the control platelets. Lysosome release was largely unaffected. This indicates that the reduction in Munc18b levels seen in the platelets from P3 does affect secretion efficacy. It is of note that there was little if any loss of syntaxin-11 in this patient's platelets ( Figure 1C and D) . This argues that the secretory defect in the heterozygous patient is largely due to a loss of Munc18b but not syntaxin-11. Furthermore, the fact that a secretion defect is noted in a heterozygous patient suggests that Munc18b could be a limiting component of the secretory machinery. A similar haploinsufficiency was noted in heterozygous Jinx mouse platelets, where it was demonstrated that Munc13-4 was a 33 As two additional measures of platelet secretion, we examined release of ADP/ATP (using the luciferin/luciferase assay in a lumi-aggregometer) and P-Selectin exposure by (FACS). ADP/ATP release is a metric of dense granule release and P-Selectin exposure is a metric of α-granule secretion. In Figure 3A , ADP/ATP was almost completely absent from platelets from the biallelic patient, P1, and P-Selectin exposure was greatly affected (64% reduction; Figure 3C ). Interestingly, α IIb β 3 integrin activation as measured by PAC-1 antibody binding was slightly affected in the platelets from patient P1 (reduced by 37%, Figure 3D) perhaps due to the lack of ADP/ATP release (reviewed in 42 ). As seen in Figure 2B , the release of ADP/ATP from dense granules of the heterozygous patient's platelets ( Figure 3B) was attenuated but not totally deficient. These data are consistent with the secretion defects seen in Figure 2 and further confirm that Munc18b plays a role in dense and α-granule cargo release.
Ultrastructure of FHL5 Platelets:
Platelet activation leads to actin cytoskeleton rearrangements that play a role in platelet secretion; 43, 44 therefore, it is possible that a loss of Munc18b affects the platelets cytoskeleton rearrangements thus indirectly affecting secretion. This is especially true given the recent studies of how Munc18-1 affects cortical F-actin in chromaffin cells. 45 To determine whether activation-dependent cytoskeletal changes were affected, both resting and thrombin-stimulated platelets from control and a biallelic FHL5 patient (P1) were examined by electron microscopy ( Figure 4) . Resting platelets had a normal discoid shape with similar distributions of identifiable granules, vacuoles, and mitochondria.
There were no overt differences in the morphology of normal and FHL5 patient's platelets. The data presented here suggests that Munc18b and syntaxin-11 levels are partially co-dependent (see Figure 1C and D) consistent with Munc18b serving as a syntaxin-11 chaperone in platelets. If Munc18b is a syntaxin-11 regulator and thus part of the platelet secretory machinery, one might expect that Munc18b could form a complex with at least the Figure 5A immunoprecipitation of Munc18b brought down syntaxin-11, SNAP-23, and VAMP-8. There was no syntaxin-4 or -7 detectible. The limited syntaxin-2 present could be the result of cross-reactivity of the blotting syntaxin-2 antibody for syntaxin-11 (see Ye et al. 2012 preceding paper). Alternatively, since the rabbit anti-Munc18b, used for these experiments, has a slight cross-reactivity for Munc18a, it could have co-precipitated Munc18b/syntaxin-2. Despite these caveats, it appears that the major cognate syntaxin for Munc18b in platelets is syntaxin-11. Under these precipitation conditions, there were no obvious differences in the complexes recovered from resting or stimulated platelets.
Similar results were obtained when a rabbit anti-syntaxin-11 polyclonal antibody was used to precipitate complexes. Munc18b as well as VAMP-8 and SNAP-23 were detected in the immunoprecipitate. This is consistent with a previous report showing that Munc18b associates with SNARE complexes purified from platelet extracts using a general affinity technique involving NSF binding. 27 These data show that Munc18b associates with syntaxin-11, and that it does interact with other components of the core fusion machinery. To expand this observation, we also probed for other elements of the secretion machinery that are known to be required. Interestingly, both Rab27a and Munc13-4 (a Rab27 effector 46 ) were found to co-precipitate with Munc18b. While this might argue that a larger "fusion" complex is present in platelets, further experiments will be required to define the interactions implied by these findings.
DISCUSSION:
The present study shows that Munc18b is more abundant than the other Munc18 isoforms present in platelets. Based on previous studies of VAMP -8 7 , syntaxin-11 (Ye et al.
2012 preceding paper), SNAP-23 [8] [9] [10] 40 , and Munc13-4 33 , it appears that the most abundant isoform of a given secretory protein family is the most functionally relevant in platelets. This conclusion is supported by the platelet phenotype of patients with FHL5, a defect in the L130S, P334L, T345M, and G542S, destabilize Munc18b leading to its degradation in platelets. Coincident with the loss of Munc18b, there were clear defects in release from dense (serotonin, and ADP/ATP) and α-granules (PF4 and P-selectin exposure). These data are consistent with the FACS-based analysis of platelets from FHL5 patients reported by
Sandrock et al. 36 The attenuated defect seen in the heterozygous patient argues that Munc18b might be a limiting component of the secretory machinery in platelets. We have seen similar results in heterozygous Unc13d Jinx mice that have reduced levels of Munc13-4. 33 The FHL5
patients' platelets showed no overt difference in morphology or granule cargo content suggesting that granule biosynthesis was normal. The phenotype of the stimulated platelets indicates that cytoskeletal changes do occur normally and that the loss of Munc18b truly affects fusion since there are intact granules in the stimulated platelets from the FHL5 patient.
The loss of Munc18b caused a decrease in syntaxin-11, consistent with earlier studies of cells from FHL5 patients. 19, 20 These data suggest that Munc18b/syntaxin-11 is a functionally relevant pair in both lymphocytes and platelets. We confirmed this via immunoprecipiation Contrary to the data presented here, previous studies, using potential inhibitors in permeabilized platelets, had established the importance of Munc18s in platelet secretion. Our own work with peptides, thought to affect Munc18s' interactions with other regulators such as Rabs, showed that Munc18s were needed. 27 However, the sequences were highly conserved and thus we could not establish which Munc18 isoform was required for calcium-stimulated release. Other studies used a cocktail of peptides and a monoclonal antibody to disrupt Munc18c/syntaxin-4 complexes. These reagents enhanced release from permeabilized platelets. 26, 40 Such results supported an original hypothesis that Munc18s were negative regulators of syntaxins, preventing their interactions with other SNAREs, and thus were "brakes" on secretion. However, in recent years, our understanding of Munc18 function has expanded. It is now thought that some Munc18s stay associated with SNAREs throughout the secretion process and actually contribute to membrane fusion. 11 The data presented here and that reported by Schraw et al. 27 , argue that, in platelets, Munc18b stays associated with the complete SNARE complex not just the t-SNARE heterodimer (syntaxin/SNAP-23).
Other initial observations were also clarified by the data presented here. 
